Latest news

Останні новини

thumbnail_Group 642.png

Group 642.png

As the holder of the first international value-added medicine patent – liquid&nbsp;Omeprazole, ready to use – Alkaloid sponsored the First International Conference on Modern Approaches to GERD Treatment in Pediatric Patients, held in Zagreb, Croatia.

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE SOLUTIONS IN PEDIATRIC GERD TREATMENT HELD IN ZAGREB

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE

ALKALOID reached consolidated sales of EUR 84.5 million, consolidated export of EUR 57.4 million and invested EUR 4.2 million in the January – March 2025 period.

Visit your local Alkaloid website

Serbia

Romania

Croatia

Ukraine

Bulgaria

Bosnia and Herzegovina

Latest news

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE

ALKALOID – operating results for the January – March 2025 period